Phase II trial of trametinib in combination with the AKT inhibitor GSK 2141795 in BRAF wild-type melanoma Meeting Abstract
| Authors: | Algazi, A. P.; Muthukumar, A. H.; O'Brien, K.; Lencioni, A.; Tsai, K. K.; Kadafour, M.; Chapman, P. B.; Daud, A. |
| Abstract Title: | Phase II trial of trametinib in combination with the AKT inhibitor GSK 2141795 in BRAF wild-type melanoma |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901978 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.9068 |
| Notes: | Meeting Abstract: 9068 -- Source: Wos |
